Malignant hyperthermia: a pharmacogenetic disorder.

doi:10.3928/01477447-20090922-18

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Malignant hyperthermia: a pharmacogenetic disorder.

Orthopedics - 1 Nov 2009

Stratman Rachel C, Flynn Jeremy D, Hatton Kevin W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Malignant Hyperthermia
Share to Mutation
Share to Ryanodine Receptor Calcium Release Channel

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Syndrome

Source

Open in PubMed

Identifiers

PMID: 19902883
DOI: 10.3928/01477447-20090922-18

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Malignant hyperthermia: a pharmacogenetic disorder.PMID 19902883Read ↗

Malignant Hyperthermia Susceptibility and Related DiseasesSemantic proximity Read ↗

Malignant hyperthermia: advances in clinical management and diagnosis.Semantic proximity Read ↗

The genetic basis of malignant hyperthermia.Semantic proximity Read ↗

A genetic mystery in malignant hyperthermia 'solved'?Semantic proximity Read ↗

Scientific advances in the genetic understanding and diagnosis of malignant hyperthermia.Semantic proximity Read ↗

Definitive diagnosis of malignant hyperthermia susceptibility by genetic testing: A case report.Semantic proximity Read ↗

Genetics and susceptibility to malignant hyperthermia.Semantic proximity Read ↗

Genomic Screening for Malignant Hyperthermia Susceptibility.Semantic proximity Read ↗

Malignant Hyperthermia: A Clinical Review.Semantic proximity Read ↗

Malignant hyperthermia.Semantic proximity Read ↗

Malignant hyperthermia genetic testing in North America Working Group Meeting. Bethesda, Maryland. September 4-5, 2002.Semantic proximity Read ↗

Malignant hyperthermia: a pharmacogenetic disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.